Aurora A kinase and its activator TPX2 are potential therapeutic targets in KRAS-induced pancreatic cancer

No abstract is available for this paper.

• Publication year

  2020

• Venue

  Cellular Oncology

• Publication date

  2020-03-19

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s13402-020-00498-5PMID 32193808PMCID PMC12990747
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Targeting KRAS Mutant Cancers with a Covalent G12C-Specific Inhibitor.

  2018cited by this paper
• TPX2 silencing mediated by joint action of microvesicles and ultrasonic radiation inhibits the migration and invasion of SKOV3 cells

  2018cited by this paper
• Identification of subsets of actionable genetic alterations in KRAS-mutant lung cancers using association rule mining

  2018cited by this paper
• PARP10 suppresses tumor metastasis through regulation of Aurora A activity

  2018cited by this paper
• Challenges in Ras therapeutics in pancreatic cancer.

  2017cited by this paper
• Aurora kinases: novel therapy targets in cancers

  2017cited by this paper
• AURKA, DLGAP5, TPX2, KIF11 and CKAP5: Five specific mitosis-associated genes correlate with poor prognosis for non-small cell lung cancer patients

  2017cited by this paper
• Aurora kinase A interacts with H-Ras and potentiates Ras-MAPK signaling

  2017cited by this paper
• An integrative approach unveils FOSL1 as an oncogene vulnerability in KRAS-driven lung and pancreatic cancer

  2017cited by this paper
• Oncogenic Kras drives invasion and maintains metastases in colorectal cancer

  2017cited by this paper
• Inhibition of Aurora Kinase A Induces Necroptosis in Pancreatic Carcinoma.

  2017cited by this paper
• The Aurora-A–Twist1 axis promotes highly aggressive phenotypes in pancreatic carcinoma

  2017cited by this paper
• Aurora-A Kinase as a Promising Therapeutic Target in Cancer

  2016cited by this paper
• HDAC2 promotes loss of primary cilia in pancreatic ductal adenocarcinoma

  2016cited by this paper
• Non-centrosomal TPX2-Dependent Regulation of the Aurora A Kinase: Functional Implications for Healthy and Pathological Cell Division

  2016cited by this paper
• KRAS Mutant Pancreatic Cancer: No Lone Path to an Effective Treatment

  2016cited by this paper
• Aurora kinase targeting in lung cancer reduces KRAS-induced transformation

  2016cited by this paper
• Overexpressed targeting protein for Xklp2 (TPX2) serves as a promising prognostic marker and therapeutic target for gastric cancer

  2016cited by this paper
• Allosteric modulation of AURKA kinase activity by a small-molecule inhibitor of its protein-protein interaction with TPX2

  2016cited by this paper
• TPX2 promotes glioma cell proliferation and invasion via activation of the AKT signaling pathway

  2016cited by this paper
• limma powers differential expression analyses for RNA-sequencing and microarray studies

  2015cited by this paper
• The AURKA/TPX2 axis drives colon tumorigenesis cooperatively with MYC.

  2015cited by this paper
• Abrogation of AuroraA-TPX2 by novel natural inhibitors: molecular dynamics-based mechanistic analysis

  2015cited by this paper
• TPX2 Level Correlates with Hepatocellular Carcinoma Cell Proliferation, Apoptosis, and EMT

  2015cited by this paper
• Aurora kinase A in gastrointestinal cancers: time to target

  2015cited by this paper
• TPX2: of spindle assembly, DNA damage response, and cancer

  2014cited by this paper
• Aurora kinase A inhibitors: promising agents in antitumoral therapy

  2014influential reference
• Disruption of CRAF-mediated MEK activation is required for effective MEK inhibition in KRAS mutant tumors.

  2014cited by this paper
• Molecular mechanism of Aurora A kinase autophosphorylation and its allosteric activation by TPX2

  2014cited by this paper
• TPX2 Is a Prognostic Marker and Contributes to Growth and Metastasis of Human Hepatocellular Carcinoma

  2014cited by this paper
• Dragging ras back in the ring.

  2014cited by this paper
• RAS promotes tumorigenesis through genomic instability induced by imbalanced expression of Aurora‐A and BRCA2 in midbody during cytokinesis

  2013cited by this paper
• Genomic imbalance of HMMR/RHAMM regulates the sensitivity and response of malignant peripheral nerve sheath tumour cells to aurora kinase inhibition

  2013cited by this paper
• SurvExpress: An Online Biomarker Validation Tool and Database for Cancer Gene Expression Data Using Survival Analysis

  2013cited by this paper
• A novel Aurora kinase A inhibitor MK-8745 predicts TPX2 as a therapeutic biomarker in non-Hodgkin lymphoma cell lines

  2012cited by this paper
• Overexpression of Aurora-A Enhances Invasion and Matrix Metalloproteinase-2 Expression in Esophageal Squamous Cell Carcinoma Cells

  2012cited by this paper
• Control of Aurora-A stability through interaction with TPX2

  2011cited by this paper
• TPX2 and AURKA promote 20q amplicon-driven colorectal adenoma to carcinoma progression

  2011cited by this paper
• The Aurora-A/TPX2 complex: a novel oncogenic holoenzyme?

  2010cited by this paper
• A Six-Gene Signature Predicts Survival of Patients with Localized Pancreatic Ductal Adenocarcinoma

  2010cited by this paper
• Spindle proteins in resected pancreatic head adenocarcinomas: BubR1 is an independent prognostic factor in pancreatobiliary‐type tumours

  2010cited by this paper
• Phosphorylation of p53 Is Regulated by TPX2-Aurora A in Xenopus Oocytes*S⃞

  2009cited by this paper
• Validation of TPX2 as a Potential Therapeutic Target in Pancreatic Cancer Cells

  2009cited by this paper
• Aurora-A overexpression enhances cell-aggregation of Ha-ras transformants through the MEK/ERK signaling pathway

  2009cited by this paper
• Identification of Ras-related nuclear protein, targeting protein for xenopus kinesin-like protein 2, and stearoyl-CoA desaturase 1 as promising cancer targets from an RNAi-based screen.

  2007cited by this paper
• Overexpression of aurora kinase A in mouse mammary epithelium induces genetic instability preceding mammary tumor formation

  2006cited by this paper
• A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers

  2006cited by this paper
• AURKA amplification, chromosome instability, and centrosome abnormality in human pancreatic carcinoma cells.

  2005cited by this paper
• Overexpression of Aurora-A potentiates HRAS-mediated oncogenic transformation and is implicated in oral carcinogenesis

  2005cited by this paper
• Phosphorylation by aurora kinase A induces Mdm2-mediated destabilization and inhibition of p53

  2004cited by this paper
• The mitotic serine threonine kinase, Aurora-2, is a potential target for drug development in human pancreatic cancer.

  2004cited by this paper
• Overexpression of oncogenic STK15/BTAK/Aurora A kinase in human pancreatic cancer.

  2003cited by this paper
• Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation

  1998cited by this paper
• A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers

  1998cited by this paper
• Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3.

  1996cited by this paper
• Localization of Matrix Metalloproteinase MMP-2 to the Surface of Invasive Cells by Interaction with Integrin αvβ3

  1996cited by this paper

• Current progress in targeting mitotic kinases in PDAC.

  2025cites this paper
• NKX6.3 modulation of mitotic dynamics and genomic stability in gastric carcinogenesis

  2025cites this paper
• Identification of ferroptosis-related signature predicting prognosis and therapeutic responses in pancreatic cancer

  2025cites this paper
• Research progress on the relationship between AURKA and tumorigenesis: the neglected nuclear function of AURKA

  2024cites this paper
• Integrative analysis based on the cell cycle-related genes identifies TPX2 as a novel prognostic biomarker associated with tumor immunity in breast cancer

  2024cites this paper
• AurkA/TPX2 co-overexpression in nontransformed cells promotes genome instability through induction of chromosome mis-segregation and attenuation of the p53 signalling pathway.

  2024cites this paper
• miRNA-27b-3p/TPX2 Axis Regulates Clear Cell Renal Cell Carcinoma Cell Proliferation, Invasion and Migration.

  2024cites this paper
• Integrative analysis confirms TPX2 as a novel biomarker for clinical implication, tumor microenvironment, and immunotherapy response across human solid tumors

  2024cites this paper
• Adipocytes Promote Endometrial Cancer Progression Through Activation of the SIRT1‐HMMR Signaling Axis

  2024cites this paper
• Knowledge mapping of AURKA in Oncology：An advanced Bibliometric analysis (1998–2023)

  2024cites this paper
• Transmission of Exosomal TPX2 Promotes Metastasis and Resistance of NSCLC Cells to Docetaxel

  2023cites this paper
• Environmentally sensitive fluorescent probes with improved properties for detecting and imaging PDEδ in live cells and tumor slices

  2023cites this paper
• Integrated analysis of Dendrobium nobile extract Dendrobin A against pancreatic ductal adenocarcinoma based on network pharmacology, bioinformatics, and validation experiments

  2023cites this paper
• KRAS mutation: The booster of pancreatic ductal adenocarcinoma transformation and progression

  2023cites this paper
• TPX2 expression as a negative predictor of gemcitabine efficacy in pancreatic cancer

  2023cites this paper
• Role of the TPX2/NCOA5 axis in regulating proliferation, migration, invasion and angiogenesis of breast cancer cells

  2023cites this paper
• Multifaceted Effects of Kinase Inhibitors on Pancreatic Cancer Cells Reveals Pivotal Entities with Therapeutic Implications

  2023cites this paper
• The Multikinase Inhibitor AD80 Induces Mitotic Catastrophe and Autophagy in Pancreatic Cancer Cells

  2023cites this paper
• Genome, Metabolism, or Immunity: Which Is the Primary Decider of Pancreatic Cancer Fate through Non-Apoptotic Cell Death?

  2023cites this paper
• Pan-cancer analysis and in vitro validation of the oncogenic and prognostic roles of AURKA in human cancers

  2023cites this paper
• Anti-tumor target screening of sea cucumber saponin Frondoside A: a bioinformatics and molecular docking analysis

  2023cites this paper
• TPX2 regulated by miR-29c-3p induces cell proliferation in osteosarcoma via the AKT signaling pathway

  2022cites this paper
• TPX2 Serves as a Cancer Susceptibility Gene and Is Closely Associated with the Poor Prognosis of Endometrial Cancer

  2022cites this paper
• Therapeutic Potential of Mitotic Kinases’ Inhibitors in Cancers of the Gastrointestinal System

  2022influential citation
• Comprehensive analysis of a TPX2-related TRHDE-AS1/PKIA ceRNA network involving prognostic signatures in Hepatitis B virus-infected hepatocellular carcinoma

  2022cites this paper
• Targeting K-Ras-mediated DNA damage response in radiation oncology: Current status, challenges and future perspectives

  2022cites this paper
• Single-Cell RNA Sequencing Reveals the Role of Phosphorylation-Related Genes in Hepatocellular Carcinoma Stem Cells

  2022cites this paper
• Comprehensive Analysis of the Oncogenic Role of Targeting Protein for Xklp2 (TPX2) in Human Malignancies

  2022cites this paper
• Identification of biomarkers related to glycolysis with weighted gene co‐expression network analysis in oral squamous cell carcinoma

  2021cites this paper
• Single-cell transcriptomics reveals heterogeneous progression and EGFR activation in pancreatic adenosquamous carcinoma

  2021cites this paper
• ASPM is a Novel Candidate Gene Associated with Colorectal Cancer Cell Growth

  2021cites this paper
• Nuclear localisation of Aurora-A: its regulation and significance for Aurora-A functions in cancer

  2021cites this paper
• Identification of tumor antigens and immune subtypes of pancreatic adenocarcinoma for mRNA vaccine development

  2021influential citation
• Prognostic Stratification Based on HIF-1 Signaling for Evaluating Hypoxic Status and Immune Infiltration in Pancreatic Ductal Adenocarcinomas

  2021cites this paper
• Cell death in pancreatic cancer: from pathogenesis to therapy

  2021cites this paper
• Identification of potential crucial genes associated with the pathogenesis and prognosis of pancreatic adenocarcinoma

  2020cites this paper
• Development and validation of a metastasis-related Gene Signature for predicting the Overall Survival in patients with Pancreatic Ductal Adenocarcinoma

  2020cites this paper
• Validation of a Metastasis-related Gene Signature for Predicting the Overall 1 Survival in Patients with Pancreatic Ductal Adenocarcinoma 2 3 Running head : Novel Pancreatic Cancer Prognostic Tools 4 5

  2020cites this paper